BMO Capital Maintains Outperform on Andersons, Raises Price Target to $90
BMO Capital analyst Benjamin Mayhew maintains Andersons (NASDAQ:ANDE) with a Outperform and raises the price target from $75 to $90.
Stocks · News reference
Filed: 2026-10-23 AccNo: 0000821026-26-000134 Size: 441 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
BMO Capital analyst Benjamin Mayhew maintains Andersons (NASDAQ:ANDE) with a Outperform and raises the price target from $75 to $90.
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came out today.